The Role of JAK2 Mutation in Polycythaemia Vera in Some Iraqi Patients

  • Khaleed J. Khaleel


Polycythaemia vera (PV) is a myeloproliferative disease that arises in a clonal haematopoietic stem cell and is characterized by increased red blood cell production that is independent of the mechanisms that normally regulate erythropoiesis. Evaluation of the role of JAK2 mutation had been carried out in polycythaemia vera in some Iraqi patients, from beginning June 2008 up to the 30 of November 2009,attending national center of hematology for research and treatment . Thirty two patients have been included with age range of 30-66years and ten apparently healthy control group with age range of 32-55 years. Results revealed that polycythemic patients had mean age of (50.41 ±1.71). The molecular study using amplification refractory mutation ,has clarified that (90.6%) of patients with polycythaemia vera had JAK2 mutation .According to the above results to introduce JAK2 mutation test as part of routine work in suspected patients with Polycythaemia vera.

How to Cite
KHALEEL, Khaleed J.. The Role of JAK2 Mutation in Polycythaemia Vera in Some Iraqi Patients. Iraqi Journal of Cancer and Medical Genetics, [S.l.], v. 3, n. 2, jan. 2018. ISSN 2078-6123. Available at: <>. Date accessed: 11 aug. 2020.

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.